Israel Englander Royalty Pharma PLC Call Options Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $5.13 Million - $5.86 Million	200,300 Added 2503.75%	208,300 $5.89 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $370,710 - $422,955	-13,500 Reduced 62.79%	8,000 $242,000
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $563,515 - $628,230	21,500 New	21,500 $603,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.5B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.